Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
New Early Breast Cancer Drug to Reduce Risk of Recurrence or Death Approved for Australian Women(1) 2019-03-18 20:45
VolitionRx Limited to Present at Conferences in the U.S. Next Week 2019-03-15 20:30
Adlai Nortye's Buparlisib (AN2025) Set to Become a Potential Treatment for Anti-PD-1 Non-responding Tumor in HNSCC 2019-03-15 17:06
Ortho Clinical Diagnostics' VITROS® XT MicroSlide Receives CE Mark: First Multi-test Capability Added to Proprietary MicroSlide Technology 2019-03-13 14:55
AirXpanders Provides Update on Strategic Purchasing Agreements with Several Academic Medical Centers 2019-03-13 04:20
Lucence Diagnostics to Develop AI Tools for Liver Cancer Treatment 2019-03-12 10:00
Clinical Stage Biotech Company InventisBio Inc. Closes $70 Million USD Series C Financing 2019-03-12 07:00
Corvia Medical Enters Into Agreement With Edwards Lifesciences, The Global Leader In Structural Heart Innovation 2019-03-12 01:02
Transcenta Holding announces appointment of Dr. Yi Gu as Senior Vice President and Head of Research 2019-03-11 22:30
WuXi AppTec Testing Facilities Complete Three Regulatory Inspections from US FDA, OECD, and CNAS with Excellent Results 2019-03-11 16:00
TaiwanJ Pharmaceuticals Obtained US$26M Deal for Licensing and Co-Development Contract with Newsoara Biopharma on JKB-122 Asian Rights 2019-03-09 03:57
China Biologic Reports Financial Results for the Fourth Quarter and Fiscal Year 2018 2019-03-07 06:00
China Jo-Jo Drugstores Releases 2019 Letter from the Chairman 2019-03-04 21:00
Adagene Announces a Platform Evaluation of the Dynamic Precision Library with Celgene Corporation 2019-03-04 13:06
CARsgen Therapeutics Receives IND Clearance for BCMA-CAR-T Cells from the NMPA 2019-03-01 18:00
CStone Pharmaceuticals listed on the Hong Kong Stock Exchange today 2019-02-27 10:47
China Biologic Products to Report Fourth Quarter and Fiscal Year 2018 Financial Results 2019-02-25 21:00
Foresee Pharmaceuticals Announces Successful Topline Results from Phase 3 Registration Study of LMIS 25 mg in Prostate Cancer 2019-02-21 18:30
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease 2019-02-21 16:00
Shanghai Concord Medical Cancer Center's Basic Medical Services have been Fully Covered by Medical Insurance 2019-02-20 17:41
1 224 225 226 227 228 429